Fluid homeostatic action of dapagliflozin in patients with chronic kidney disease: the DAPA-BODY TrialKentaro Oka, Daisuke Nagata, Takahiro Masuda et al.|Frontiers in Medicine|2023Cited by 16
Sodium–Glucose Cotransporter 2 Inhibitor Combined with Conventional Diuretics Ameliorate Body Fluid Retention without Excessive Plasma Volume ReductionMaki Asakura-Kinoshita, Daisuke Nagata, Takahiro Masuda et al.|Diagnostics|2024Cited by 14
SGLT2 inhibitor requires co-administration with diuretics to effectively reduce interstitial fluid retention: the DAPA-BODY trialTakahiro Masuda, Yoshiyuki Morishita, Maki Asakura-Kinoshita et al.|Hypertension Research|2025Cited by 5
Urinary β2-microglobulin as a Potential Biomarker for Early Treatment Selection: A Patient with Severe IgG4-related Tubulointerstitial NephritisDaisuke Nagata, Masato Sakai, Takahiro Masuda et al.|Internal Medicine|2025Cited by 0
Dissection in a Superficialized Brachial Artery for Hemodialysis Access: A Case ReportKosuke Yuyama, Yoshiyuki Morishita, Shota Nakada et al.|Research Square|2026Cited by 0